Recent news on

United States: Terminally Disclaimed Patent Eligible For Hatch ...  -  May 16, 2007
Mondaq News Alerts (subcription),4797413, covering dorzolamide, the active ingredient in TRUSOPT ® , a drug used to treat glaucoma. The ’413 patent issued from a continuation-in-part

Patent Term Extension is OK, Even With a Terminal Disclaimer  -  Mar 30, 2007
Patent Baristas,Merck had filed a patent application covering carbonic anhydrase inhibitors, including dorzolamide, which is the active ingredient in Trusopt®,

Fitzpatrick Cella Wins Appeal on Behalf of Merck & Co. in Trusopt ...  -  Apr 2, 2007
PharmaLive.com (press release),Merck against generic patent challenges by Hi-Tech Pharmacal Co. in a case involving glaucoma eye drug Trusopt® (dorzolamide HCl opthalmic solution).

Merck v. Hi-Tech: Steven Hird, Patent Attorney at Greenberg ...  -  Mar 29, 2007
Market Wire (press release)In this case, Merck & Co., Inc. sued Hi-Tech Pharmacal Co., Inc. to enforce a patent covering an active ingredient, dorzolamide, in response to Hi-Tech's

Merck Prevails in Significant Patent Extension Case vs. Hi-Tech ...  -  Mar 29, 2007
Seeking Alpha,...handing a victory to Merck (MRK) in its battle with Hi-Tech Pharmacal (HITK) over generic Trusopt (dorzolamide HCl opthalmic solution).

A 'Sleeper' Case, Merck v. Hi-Tech, Could Cut Length of Many ...  -  18 Jan 2007
Market Wire (press release)In this case, Merck & Co., Inc. has sued Hi-Tech Pharmacal Co., Inc. to enforce a patent covering an active ingredient, dorzolamide, in response to

Glaucoma and ADHD reimbursement criticised  -  18 Jan 2007
Polish Market,The Ministry has added a new glaucoma drug to the reimbursement list, Azopt (brynzolamide), in addition to Trusopt (dorzolamide), already on the list,

DSM accelerates anti-infective activity  Oct 19, 2006
...third phase will also involve DSM's Indian plant and is also earmarked for the second quarter of 2007 and will include the compounds atomoxetine and dorzolamide ... -OutSourcing-Pharma.com,

Study Demonstrates Benefits of Combination Treatment for Glaucoma  May 11, 2006
...latanoprost, achieved clinically significant additional reduction in intraocular pressure (IOP) when treated with Cosopt® (dorzolamide hydrochloride/timolol ... - DG News



Merck Announces Strong Full-Year and Fourth-Quarter 2005 Earnings ...  Jan 31, 2006
In the lawsuits, Merck sued to enforce a patent covering an active ingredient, dorzolamide, which is present in both TRUSOPT and COSOPT. ... - TMCnet

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional